Vitamin B7 could help doctors see where transfused platelets go
NCT ID NCT07513532
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times
Summary
This study in 12 healthy volunteers tests whether biotin (vitamin B7) can be used to label platelets so they can be tracked after transfusion. Platelets are collected, labeled with biotin, stored for 3 days, then a small radioactive tag is added before returning them to the donor. Blood samples will measure how long the labeled platelets survive in circulation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Biotin-labeled platelets
- What this could lead to
- If successful, this could provide a safer, simpler way to track transfused platelets in the body, improving transfusion medicine.
- What could go wrong
- This is a very early, small study in only 12 healthy people. It tests a labeling method, not a treatment, so it won't directly help patients yet.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bloodworks Northwest Research Institute
Seattle, Washington, 98102, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults